Food and Drug Administration

Nonprescription Drugs Advisory Committee Meeting

March 23, 2005

 

Briefing Information

Disclaimer

Portions of these documents may have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. 552). These redacted portions will appear as white space on the screen or on the printed page.

 

Food and Drug Administration

Disclaimer

This briefing document has been prepared by the Food and Drug Administration (FDA) for the panel members of the advisory committee. The FDA background package often includes initial and/or preliminary conclusions and recommendations written by individual FDA reviewers. These conclusions and recommendations do not necessarily represent the final position of the individual reviewers, nor do they necessarily represent the final position of the FDA. The FDA will not issue a final determination on the issues at hand until input from the advisory committee process has been considered and all reviews have been completed.

 

FDA Briefing Information Table of Contents

 

 

The Soap and Detergent Association

and

The Cosmetic, Toiletry, and Fragrance Association

Disclaimer

The statements contained in this document(s) are not those of the FDA, and FDA does not necessarily agree with these statements. FDA has not made a final determination about the issues to be discussed at the Advisory Committee meeting.

SDA and CTFA Briefing Material